Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Aurinia Pharmaceuticals' (AUPH) CEO Peter Greenleaf on Q3 2021 Results - Earnings Call Transcript
01:26pm, Wednesday, 03'rd Nov 2021
Aurinia Pharmaceuticals' (AUPH) CEO Peter Greenleaf on Q3 2021 Results - Earnings Call Transcript
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals
10:15am, Wednesday, 03'rd Nov 2021
The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on.
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Lags Revenue Estimates
08:26am, Wednesday, 03'rd Nov 2021
Aurinia (AUPH) delivered earnings and revenue surprises of -25.81% and -0.24%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Aurinia Pharmaceuticals: Q3 Earnings Insights
08:05am, Wednesday, 03'rd Nov 2021
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the announcement.
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
07:07am, Wednesday, 27'th Oct 2021
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that it will release its third quarter 2021 financial results on Wednesday,
Aurinia (AUPH) Surges 6.6%: Is This an Indication of Further Gains?
06:00am, Tuesday, 26'th Oct 2021
Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
2 Biotech Stocks That Could Go Parabolic This Week
10:15am, Sunday, 24'th Oct 2021
These stocks could soon take flight.
Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today
09:13pm, Friday, 22'nd Oct 2021
The biotech is reportedly in buyout talks with Bristol Myers Squibb.
Bristol Myers interested in buying Aurinia Pharma - Bloomberg News
05:38pm, Friday, 22'nd Oct 2021
Bristol Myers Squibb Co has expressed interest in buying autoimmune disease drug developer Aurinia Pharmaceuticals Inc, Bloomberg News reported on Friday, citing people familiar with the matter.
2 Best Biotech Stocks to Buy Right Now
07:00am, Saturday, 25'th Sep 2021
Aurinia Pharmaceuticals and Axsome Therapeutics are two names that growth investors should have on their radars right now.
Implied Volatility Surging for Aurinia (AUPH) Stock Options
10:43am, Monday, 20'th Sep 2021
Investors need to pay close attention to Aurinia (AUPH) stock based on the movements in the options market lately.
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
01:11pm, Wednesday, 15'th Sep 2021
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will present at the following up
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
01:30pm, Friday, 10'th Sep 2021
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will participate in the H.C. Wai
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
11:29am, Wednesday, 18'th Aug 2021
Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.
Aurinia (AUPH) Adds Two Candidates, Boosts Immunology Pipeline
11:29am, Wednesday, 18'th Aug 2021
Aurinia (AUPH) acquires two pre-clinical, novel pipeline programs for the treatment of rare autoimmune, fibrotic and kidney diseases. Yet, the stock price declines.
